Monday, Nov 13, 2017 8:20a -
Tuesday, Nov 14, 2017 3:45p
Hyatt Regency Boston Harbor
One Avenue de Lafayette
Boston, Massachusetts 02111
$2399 - 2699
Lectures & Conferences
This Anti-Fibrotic Drug Development conference will be a unique opportunity for drug developers focused on organ-specific indications to participate in a cross-disciplinary, multi-organ discussions in order to gain new insights into their anti-fibrotic drug development research.
Attending this comprehensive forum will enable you to; identify which fibrotic mechanisms are driving pathology changes in humans; effectively translate from preclinical to clinical development and robustly select patient populations.
Register by August 18 to save $300: USD 2399
Register by September 8 to save $200: USD 2499
Register by October 6 to save $100: USD 2599
Standard Rate: USD 2699
Speakers: Ray Jupp (UCB), Richard Marshall (GSK), Lisa Hazelwood (AbbVie), Peter Blume-Jensen (Xtuit Pharmaceuticals), Alexey Lugovskoy (Morphic Therapeutics), Seth Porter (FibroGen)